Abstract
The involvement of immunological reactivity to ranitidine base (R-b) and ranitidine hydrochloride (R-HCl) in the development of occupationally related symptomatology was analyzed in 40 subjects employed in a pharmaceutical plant producing ranitidine and in 33 nonexposed controls, using a specific dose-response lymphocyte proliferative test (lymphocyte transformation test: LTT). Of the 40 workers, 11 (28%) gave positive reactions to LTT: 3/11 to R-b, 4/11 to R-HCl, and 4/11 to both compounds. None of the controls gave positive reactions. Cutaneous, oculonasal, or respiratory work-related symptoms were cited by 23 of the 40 (58%) subjects; ten of these 23 subjects (43%) were LTT positive. One asymptomatic case was LTT positive. The present results indicate that specific immune reactivity to ranitidine, analyzed by LTT, is associated with the presence of occupational symptomatology; R-HCl and R-b seem to share some antigenic determinants, because of the partial cross-reactivity shown by the examined compounds. Nonimmunological, probably irritative, mechanisms are also present in some of the symptomatic subjects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Alomar A, Puig L, Vilaltella I (1987) Allergic contact dermatitis due to ranitidine. Contact Dermatitis 17:54–55
Brayko CM (1984) Ranitidine. N Engl J Med 310:1601–1602
Eandi M, DeCarli GF, Recchia G, Colonna CV (1990) Ranitidine: eight years of post-marketing drug surveillance. Post Marketing Surveillance 4:1–8
Goh CL, Ng SK (1984) Allergic contact dermatitis to ranitidine. Contact Dermatitis 11:252
Greer IA, Fellows K (1990) Anaphylactoid reaction to ranitidine in labour. Br J Clin Pharmacol 44:78
Haboubi N, Asquith P (1988) Rash mediated by immune complexes associated with ranitidine treatment. Br Med J 296:897
Lancaster-Smith MJ, Jaderberg ME, Jackson DA (1991) Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 32:252–255
Lazaro M, Compaired JA, De La Hoz B, Igea JM, Davila I, Losada E (1993) Anaphylactic reaction to ranitidine. Allergy 48:385–387
Mills JG, Castelli G, Uleri S, Wood JR (1991) Ranitidine. In: Braga PC, Guslandi M, Tittobello A (eds) Drugs in gastroenterology. Raven, New York, pp 116–133
Penston JG, Wormsley KG (1992) Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Alim Pharmacol Ther 6:629–645
Picardo M, Santucci B (1983) Urticaria from ranitidine. Contact Dermatitis 9:327
Romaguera C, Grimalt F, Vilaplana J (1988) Epidemic of occupational contact dermatitis from ranitidine. Contact Dermatitis 18:177–178
Romaguera C, Grimalt F, Vilaplana J (1990) Contact dermatitis caused by intermediate products in the manufacture of clenbuterol, ranitidine base and ranitidine hydrochloride. Dermatol Clin 8:115–117
Rycroft RJG (1983) Allergic contact dermatitis from a novel diamino intermediate, 5-((2-aminoethyl)tiomethyl)-N,N-dimethyl-2-furanmethanamine, in laboratory synthesis. Contact Dermatitis 9:456–458
Simon B, Muller P, Dammann HG (1982) Safety profile of ranitidine. In: Riley AJ, Salomon PR (eds) Ranitidine: proceedings of an international symposium held in the context of the seventh World Congress of Gastroenterology. Excepta Medica, Amsterdam, pp 181–189
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Riviera, A.P., Pezzini, A., Zanom, G. et al. Immunological reactivity in ranitidine factory workers. Int. Arch Occup Environ Heath 66, 407–411 (1995). https://doi.org/10.1007/BF00383148
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00383148